GO:0051548 negative regulation of keratinocyte migration: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051548 describes any process that stops, prevents, or reduces the frequency, rate or extent of keratinocyte migration.
• Negative regulation of keratinocyte migration is essential for re-epithelialization control during wound healing and for preventing aberrant epidermal invasion.
• Key molecular brakes include SOCS3/CIS3, which inhibits STAT3-dependent HGF-induced migration, and CD9, which negatively modulates ADAM17 sheddase activity.
• Autophagy and TLR4 signaling intersect with migration control, influencing keratinocyte activation and proliferation during skin repair.
• Dysregulation of this process contributes to chronic wounds, psoriasis, and cutaneous squamous cell carcinoma progression.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of negative regulators in keratinocyte migration.
Description
Keratinocyte migration is a fundamental step in re-epithelialization, the process by which the epidermis restores its barrier after injury. To prevent uncontrolled or misdirected movement, cells deploy negative regulatory mechanisms that stop, prevent, or reduce the frequency, rate, or extent of keratinocyte migration, formally annotated as GO:0051548. This biological process is not merely a passive brake; it coordinates the timing and spatial restriction of migration so that wound closure proceeds efficiently without excessive or invasive behavior. Understanding negative regulation of keratinocyte migration is therefore critical for researchers studying skin homeostasis, wound repair, and epidermal pathologies. At the molecular level, negative regulation of keratinocyte migration is mediated by signaling suppressors, surface receptors, and proteolytic regulators that intersect with growth factor pathways. For example, SOCS3/CIS3 negatively regulates STAT3 in hepatocyte growth factor (HGF)-induced keratinocyte migration, providing a direct intracellular checkpoint. CD9, a tetraspanin, restrains keratinocyte migration by negatively modulating the sheddase activity of ADAM17, linking membrane organization to migratory suppression. These examples illustrate that GO:0051548 encompasses diverse molecular strategies to temper keratinocyte motility. Beyond individual molecules, negative regulation of keratinocyte migration is embedded in broader processes such as autophagy and innate immune signaling. Keratinocyte autophagy enables the activation of keratinocytes and fibroblasts and facilitates wound healing, indicating that autophagic pathways can influence the balance between migration and repair. TLR4 acts as a negative regulator of keratinocyte proliferation, and such signaling nodes may indirectly shape migratory outcomes. This article synthesizes the current understanding of GO:0051548, its key genes, regulatory mechanisms, disease relevance, and the CRISPR-based methods used to study it.
negative regulation of keratinocyte migration At A Glance
| GO ID | GO:0051548 |
|---|---|
| GO term | negative regulation of keratinocyte migration |
| Ontology | biological_process |
| Synonym | down regulation of keratinocyte migration; down-regulation of keratinocyte migration; downregulation of keratinocyte migration; inhibition of keratinocyte migration |
| Major function | Stops, prevents, or reduces the frequency, rate or extent of keratinocyte migration |
| Related process | Regulation of keratinocyte migration; keratinocyte migration; wound healing |
| Key regulators | SOCS3/CIS3, CD9, ADAM17, STAT3, TLR4, autophagy-related proteins |
| Disease relevance | Chronic wounds, psoriasis, cutaneous squamous cell carcinoma |
| Research methods | CRISPR knockout, knock-in, overexpression, live-cell imaging, RNA-seq, proteomics |
What Is GO:0051548?
GO:0051548, negative regulation of keratinocyte migration, is defined as any process that stops, prevents, or reduces the frequency, rate or extent of keratinocyte migration. In other words, it covers the cellular and molecular events that put the brakes on the movement of keratinocytes, the predominant cell type in the epidermis. This regulation can occur through intracellular signaling suppressors, surface receptor interactions, or extracellular cues that collectively limit keratinocyte motility.
Why Is negative regulation of keratinocyte migration Important in Cell Biology?
Negative regulation of keratinocyte migration is important because it ensures that epidermal repair is spatially and temporally controlled, preventing excessive or invasive keratinocyte movement that could impair wound healing or contribute to skin pathology. Dysregulation of this process is linked to chronic non-healing wounds, inflammatory skin diseases, and skin cancers, making it a key area for therapeutic and diagnostic research.
• Controls re-epithelialization during wound healing to avoid uncontrolled keratinocyte invasion.
• Prevents aberrant epidermal migration that can contribute to chronic wounds and skin tumors.
• Provides molecular checkpoints such as SOCS3/CIS3-mediated inhibition of STAT3 signaling.
• Involves surface proteins like CD9 that modulate ADAM17 sheddase activity to restrain migration.
• Intersects with autophagy, which supports keratinocyte activation and fibroblast function in repair.
• Links to innate immune signaling through TLR4, which negatively regulates keratinocyte proliferation.
• Offers targets for therapeutic modulation in psoriasis and cutaneous squamous cell carcinoma.
• Enables mechanistic studies using CRISPR-based gene editing to dissect causal regulators.
• Helps explain how growth factor pathways (e.g., HGF) are tempered to balance migration and repair.
• Supports development of biomarkers and interventions for skin regeneration and cancer.
What Happens During negative regulation of keratinocyte migration?
Initiation of negative regulatory signals
In simple terms: The cell receives signals that tell it to slow down or stop moving.
Negative regulation of keratinocyte migration begins when extracellular or intracellular cues activate suppressive pathways. For instance, SOCS3/CIS3 is induced and acts as a negative regulator of STAT3 in HGF-induced keratinocyte migration, directly dampening a pro-migratory signaling axis. Similarly, CD9 on the keratinocyte surface can initiate negative regulation by modulating the sheddase activity of ADAM17, thereby reducing migratory capacity. These initial signals set the stage for downstream events that limit motility.
Suppression of pro-migratory signaling
In simple terms: Inside the cell, specific proteins block the signals that would normally drive movement.
Once negative regulatory signals are engaged, intracellular suppressors interfere with pro-migratory pathways. SOCS3/CIS3 negatively regulates STAT3, a transcription factor that promotes HGF-induced keratinocyte migration, thereby reducing the expression of genes required for movement. In parallel, CD9-mediated negative modulation of ADAM17 sheddase activity decreases the release of membrane-bound factors that would otherwise enhance migration. This step ensures that pro-migratory cues are counterbalanced by inhibitory molecules.
Cytoskeletal and adhesion remodeling
In simple terms: The cell's internal skeleton and its grip on the surface are adjusted to reduce movement.
Negative regulation of keratinocyte migration also involves changes in the cytoskeleton and cell-matrix adhesion, although specific molecular details in the context of GO:0051548 are still being resolved. The net effect is a reduced frequency, rate, or extent of migration, as defined by the GO term. Autophagy-related processes may contribute to these remodeling events, as keratinocyte autophagy enables the activation of keratinocytes and fibroblasts and facilitates wound healing, suggesting a complex interplay between autophagic machinery and migratory control.
Integration with wound healing and tissue repair
In simple terms: The braking process is coordinated with the overall repair of the skin.
Negative regulation of keratinocyte migration is integrated into the broader context of wound healing. Autophagy in keratinocytes supports the activation of keratinocytes and fibroblasts, facilitating wound healing, which implies that negative regulatory mechanisms must be finely tuned to allow repair while preventing excessive migration. TLR4 acts as a negative regulator of keratinocyte proliferation, and such innate immune signaling may indirectly influence the migratory balance during tissue repair. Thus, GO:0051548 is not an isolated event but part of a coordinated repair response.
Resolution and return to homeostasis
In simple terms: Once repair is complete, the brakes remain on to keep the skin stable.
After wound closure, sustained negative regulation of keratinocyte migration helps return the epidermis to a homeostatic state. Failure of this resolution can contribute to pathological conditions such as chronic wounds or hyperproliferative skin diseases. In cutaneous squamous cell carcinoma, dysregulated migration and invasion are hallmarks, and negative regulators such as GSTM3-mediated ferroptosis pathways may influence tumor suppression. Therefore, the resolution phase of GO:0051548 is critical for long-term skin health.
Key Genes Involved in GO:0051548 negative regulation of keratinocyte migration
The following genes and proteins have been implicated in negative regulation of keratinocyte migration or closely related regulatory processes, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOCS3 | Negatively regulates STAT3 in HGF-induced keratinocyte migration | Key intracellular brake; target for migration assays and STAT3 pathway studies |
| CIS3 | Negative regulator of STAT3 signaling | Modulates HGF-induced migration; studied alongside SOCS3 |
| STAT3 | Pro-migratory transcription factor suppressed by SOCS3/CIS3 | Central node in HGF-induced keratinocyte migration |
| CD9 | Tetraspanin that negatively modulates ADAM17 sheddase activity | Surface regulator of keratinocyte migration; target for adhesion and protease studies |
| ADAM17 | Sheddase whose activity is negatively modulated by CD9 | Proteolytic regulator of migration; studied in CD9 loss- and gain-of-function models |
| TLR4 | Negative regulator of keratinocyte proliferation | Innate immune receptor influencing keratinocyte behavior; relevant to migration control |
| ATG5 | Autophagy-related protein enabling keratinocyte activation | Links autophagy to wound healing and migratory balance |
| ATG7 | Autophagy-related protein involved in keratinocyte autophagy | Supports keratinocyte and fibroblast activation during repair |
| BECN1 | Autophagy regulator in skin wound healing | Potential modulator of keratinocyte migration through autophagic pathways |
| MAP1LC3B | Autophagosome marker in keratinocytes | Used to monitor autophagy during migration studies |
| GSTM3 | Glutathione S-transferase involved in ferroptosis suppression | Target of echinatin in cutaneous squamous cell carcinoma; linked to tumor suppression |
| HGF | Growth factor that induces keratinocyte migration | Upstream stimulus whose effects are tempered by SOCS3/CIS3 |
| MET | HGF receptor tyrosine kinase | Initiates pro-migratory signaling that is subject to negative regulation |
| EGFR | Growth factor receptor influencing keratinocyte motility | Potential integration node for negative regulatory cues |
| ITGB1 | Integrin subunit involved in cell-matrix adhesion | Adhesion remodeling during migration suppression |
| CD151 | Tetraspanin partner of CD9 | May cooperate with CD9 in regulating ADAM17 activity |
| TIMP3 | Endogenous inhibitor of sheddases | Potential modulator of ADAM17-dependent migration |
| NFKB1 | Transcription factor downstream of TLR4 | Links innate immune signaling to keratinocyte proliferation and migration |
How Is negative regulation of keratinocyte migration Regulated?
Negative regulation of keratinocyte migration is controlled by multiple intersecting pathways. SOCS3/CIS3 provides a direct intracellular checkpoint by inhibiting STAT3 in HGF-induced migration, thereby limiting the transcriptional output that drives motility. CD9 negatively modulates ADAM17 sheddase activity, adding a membrane-level regulatory layer that restrains the release of pro-migratory factors. Autophagy-related proteins such as ATG5 and ATG7 enable keratinocyte activation and fibroblast function during wound healing, indicating that autophagic flux can influence the balance between migration and repair. TLR4 signaling acts as a negative regulator of keratinocyte proliferation, and such innate immune inputs may indirectly shape migratory outcomes. Together, these mechanisms ensure that keratinocyte migration is tightly controlled in space and time.
negative regulation of keratinocyte migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SOCS3 | Chronic wounds, impaired STAT3 regulation | Keratinocyte-specific SOCS3 knockout and overexpression in scratch assays |
| CD9 | Aberrant keratinocyte migration, skin tumor progression | CD9 knockout and knock-in keratinocytes with ADAM17 activity readouts |
| TLR4 | Psoriasis, inflammatory skin disease | TLR4 knockout keratinocytes in proliferation and migration assays |
| GSTM3 | Cutaneous squamous cell carcinoma | GSTM3 knockout and overexpression in skin cancer cell lines |
| ATG5 | Chronic wounds, defective autophagy | ATG5 knockout keratinocytes in wound healing models |
Chronic wounds and impaired healing
Defects in the negative regulation of keratinocyte migration can contribute to chronic non-healing wounds, where migration is either excessive or improperly timed, disrupting re-epithelialization. Autophagy and keratinocyte activation are critical for wound healing, and their dysregulation may impair the coordinated braking of migration. Understanding GO:0051548 in this context may inform therapies for diabetic ulcers and other chronic wounds.
Psoriasis and inflammatory skin disease
Psoriasis is characterized by hyperproliferation and abnormal keratinocyte behavior, and negative regulators such as TLR4, which restrains keratinocyte proliferation, may be relevant to disease pathogenesis. Altered negative regulation of keratinocyte migration could contribute to the aberrant epidermal turnover seen in psoriatic lesions. Targeting these pathways may offer new approaches for inflammatory skin conditions.
Cutaneous squamous cell carcinoma
In cutaneous squamous cell carcinoma, loss of negative regulatory mechanisms can permit invasive keratinocyte migration and tumor progression. Echinatin suppresses cutaneous squamous cell carcinoma by targeting GSTM3-mediated ferroptosis, highlighting a tumor-suppressive pathway that intersects with migration control. Restoring negative regulation of keratinocyte migration may therefore have therapeutic potential in skin cancer.
Primary atopic disorders and genomic diagnosis
Primary atopic disorders can present with skin manifestations, and rapid identification using clinical landmark-guided genomic sequencing is improving diagnosis. While not directly about keratinocyte migration, such genomic approaches may reveal variants in genes that influence skin barrier and migratory regulation. This underscores the broader clinical relevance of understanding epidermal cell behavior.
From negative regulation of keratinocyte migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SOCS3 increase keratinocyte migration? | SOCS3 knockout keratinocytes in HGF-induced migration assays |
| Does CD9 negatively regulate ADAM17 sheddase activity? | CD9 knockout and CD9 overexpression keratinocytes with ADAM17 activity measurements |
| How does TLR4 signaling affect keratinocyte proliferation and migration? | TLR4 knockout and point-mutation keratinocytes |
| What is the role of autophagy in keratinocyte activation during wound healing? | ATG5 or ATG7 knockout keratinocytes in in vitro scratch and in vivo wound models |
| Can GSTM3-mediated ferroptosis suppress cutaneous squamous cell carcinoma? | GSTM3 knockout and knock-in skin cancer cells treated with echinatin |
| How do STAT3 mutations affect negative regulation of migration? | STAT3 point-mutation knock-in keratinocytes |
How to Study the negative regulation of keratinocyte migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Scratch wound assay | Rate of keratinocyte migration into a gap | Testing negative regulators in vitro |
| Transwell migration assay | Number of cells migrating through a membrane | Quantifying suppression of migration |
| Live-cell time-lapse imaging | Speed, directionality, and persistence of migration | Dynamic analysis of GO:0051548 |
| RNA sequencing | Transcriptional changes associated with migration suppression | Identifying downstream targets of SOCS3/STAT3 |
| Proteomics | Protein abundance and post-translational modifications | Detecting ADAM17 regulation by CD9 |
| Sheddase activity assay | Proteolytic cleavage of ADAM17 substrates | Measuring CD9-mediated negative modulation |
| LC3B lipidation assay | Autophagic flux | Linking autophagy to keratinocyte migration |
| Immunofluorescence | Localization of migration-related proteins | Visualizing cytoskeletal and adhesion changes |
Live-cell imaging and migration assays
Live-cell imaging combined with scratch wound assays or transwell migration assays allows direct measurement of keratinocyte migration rates and the impact of negative regulators. Time-lapse microscopy can quantify speed, directionality, and persistence, providing functional readouts for GO:0051548.
RNA sequencing and transcriptomics
RNA sequencing of keratinocytes under conditions that activate or suppress migration can reveal transcriptional programs controlled by negative regulators such as SOCS3/CIS3 and STAT3. Differential expression analysis identifies genes whose expression correlates with reduced migration.
Proteomics and sheddase activity assays
Proteomic approaches and specific sheddase activity assays can measure ADAM17 activity and its modulation by CD9, providing biochemical evidence for negative regulation of keratinocyte migration. These methods help link surface protein interactions to functional outcomes.
Autophagy flux analysis
Autophagy flux can be monitored using LC3B lipidation assays, autophagosome markers, and electron microscopy in keratinocytes, as autophagy enables keratinocyte activation and wound healing. Such analyses help determine how autophagic pathways intersect with migratory control.
How CRISPR Can Be Used to Study GO:0051548 negative regulation of keratinocyte migration
Knockout
CRISPR knockout of candidate negative regulators such as SOCS3 or CD9 in keratinocytes enables loss-of-function studies to test whether their removal increases migration. Knockout models are essential for establishing causality in GO:0051548.
Point Mutation
Point mutations can be introduced into genes like STAT3 to disrupt specific phosphorylation or interaction sites, allowing precise dissection of signaling events that are subject to negative regulation. Such models help distinguish between different functional domains.
Knock-in
Knock-in of tagged or reporter versions of genes such as CD9 or ADAM17 allows real-time tracking of protein localization and activity during keratinocyte migration. This approach provides spatial and temporal resolution of negative regulatory events.
Overexpression
Overexpression of negative regulators like SOCS3 or CD9 in keratinocytes can confirm their ability to suppress migration and identify downstream effects. Overexpression models are useful for gain-of-function studies and for testing therapeutic candidates.
How EDITGENE Supports negative regulation of keratinocyte migration Research
Researchers studying negative regulation of keratinocyte migration-related genes often need to determine whether a candidate gene is causally involved in suppressing motility or is merely correlated with changes in migration. CRISPR-based gene editing provides the gold standard for such causal inference, enabling precise knockout, point mutation, knock-in, and overexpression in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of keratinocyte migration research.
Frequently Asked Questions About negative regulation of keratinocyte migration
What is negative regulation of keratinocyte migration?
It is the biological process that stops, prevents, or reduces the frequency, rate or extent of keratinocyte migration, annotated as GO:0051548.
What genes are involved in negative regulation of keratinocyte migration?
Key genes include SOCS3, CIS3, CD9, ADAM17, STAT3, TLR4, and autophagy-related genes such as ATG5 and ATG7.
How does SOCS3 regulate keratinocyte migration?
SOCS3/CIS3 negatively regulates STAT3 in HGF-induced keratinocyte migration, reducing pro-migratory signaling.
What is the role of CD9 in keratinocyte migration?
CD9 negatively modulates the sheddase activity of ADAM17, thereby restraining keratinocyte migration.
How is autophagy linked to keratinocyte migration?
Keratinocyte autophagy enables the activation of keratinocytes and fibroblasts and facilitates wound healing, influencing the balance of migration.
What diseases are associated with dysregulated keratinocyte migration?
Chronic wounds, psoriasis, and cutaneous squamous cell carcinoma are associated with dysregulated keratinocyte migration.
How can CRISPR be used to study negative regulation of keratinocyte migration?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in keratinocytes.
What methods measure negative regulation of keratinocyte migration?
Scratch wound assays, transwell migration, live-cell imaging, RNA-seq, proteomics, and sheddase activity assays are commonly used.
What is the GO ID for negative regulation of keratinocyte migration?
The GO ID is GO:0051548.
Why is negative regulation of keratinocyte migration important in wound healing?
It ensures that re-epithelialization is controlled and prevents excessive or invasive keratinocyte movement during repair.
Conclusion
Negative regulation of keratinocyte migration (GO:0051548) is a critical biological process that tempers keratinocyte motility to ensure proper wound healing and tissue homeostasis. Key regulators such as SOCS3/CIS3, CD9, and autophagy-related proteins provide molecular brakes that are essential for preventing pathological migration. Dysregulation of this process is linked to chronic wounds, inflammatory skin diseases, and skin cancer, making it a compelling area for therapeutic research. CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, offer powerful tools to dissect the causal roles of specific genes in GO:0051548. By combining these models with functional assays and bioinformatics, researchers can accelerate the discovery of new targets and interventions for skin repair and disease.
References
- 1. Qiang L et al.. 2021. Keratinocyte autophagy enables the activation of keratinocytes and fibroblastsand facilitates wound healing.. Autophagy 17(9):2128-2143 PMID: 32866426
- 2. Niehues T et al.. 2024. Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing.. Allergol Select 8:304-323 PMID: 39381601
- 4. Iotzova-Weiss G et al.. 2017. TLR4 as a negative regulator of keratinocyte proliferation.. PLoS One 12(10):e0185668 PMID: 28982115
- 5. Tokumaru S et al.. 2005. SOCS3/CIS3 negative regulation of STAT3 in HGF-induced keratinocyte migration.. Biochem Biophys Res Commun 327(1):100-5 PMID: 15629435
- 6. Ren H et al.. 2022. Autophagy and skin wound healing.. Burns Trauma 10:tkac003 PMID: 35187180
- 7. Liu J et al.. 2019. CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17.. Int J Biol Sci 15(2):493-506 PMID: 30745837
- 8. Kang Z et al.. 2024. Echinatin suppresses cutaneous squamous cell carcinoma by targeting GSTM3-mediated ferroptosis.. Phytomedicine 131:155752 PMID: 38833947
